Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingGlobe Newswire • 26 days ago
Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data show non-classical EGFR mutations can be co-expressed with the classical...
Share to Feed
CAMBRIDGE, Mass. and NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target...
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX Get Free Report) was the recipient of a significant decrease in short interest during the month of February. As of February 29th, there was short...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Black Diamond Therapeutics (NASDAQ:BDTX Get Free Report)s stock had its buy rating restated by research analysts at HC Wainwright in a report issued on Monday, Benzinga...
BDTX Advances in Oncology with Key Clinical Trials and Maintains Strong Cash PositionRelated Stocks: BDTX...
Dosed first patient in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCClinical data on track for Q3 2024 in Phase 2 trial of BDTX-1535 in 2L/3L patients with acquired...
Abstract accepted for oral presentation on the evolving EGFR mutational landscape in NSCLC and MasterKey profile of BDTX-1535 addressing a broad spectrum of mutationsCAMBRIDGE, Mass., March 05, 2024...
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 15th, there was short...
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX Get Free Report) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling...